410 related articles for article (PubMed ID: 19577568)
21. Combined Low Densities of FoxP3
Cavalleri T; Bianchi P; Basso G; Celesti G; Grizzi F; Bossi P; Greco L; Pitrone C; Valtorta E; Mauri G; Truini M; Dall'Olio FG; Brandi G; Sartore-Bianchi A; Ricciardiello L; Torri V; Rimassa L; Siena S; Mantovani A; Malesci A; Laghi L;
Cancer Immunol Res; 2019 May; 7(5):751-758. PubMed ID: 30804005
[TBL] [Abstract][Full Text] [Related]
22. The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.
Ling A; Edin S; Wikberg ML; Öberg Å; Palmqvist R
Br J Cancer; 2014 May; 110(10):2551-9. PubMed ID: 24675384
[TBL] [Abstract][Full Text] [Related]
23. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
24. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
[TBL] [Abstract][Full Text] [Related]
25. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
[TBL] [Abstract][Full Text] [Related]
26. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Shiovitz S; Bertagnolli MM; Renfro LA; Nam E; Foster NR; Dzieciatkowski S; Luo Y; Lao VV; Monnat RJ; Emond MJ; Maizels N; Niedzwiecki D; Goldberg RM; Saltz LB; Venook A; Warren RS; Grady WM;
Gastroenterology; 2014 Sep; 147(3):637-45. PubMed ID: 24859205
[TBL] [Abstract][Full Text] [Related]
27. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
[TBL] [Abstract][Full Text] [Related]
29. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
30. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
[TBL] [Abstract][Full Text] [Related]
31. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
32. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
[TBL] [Abstract][Full Text] [Related]
33. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.
Allard MA; Bachet JB; Beauchet A; Julie C; Malafosse R; Penna C; Nordlinger B; Emile JF
Diagn Pathol; 2012 Nov; 7():156. PubMed ID: 23148481
[TBL] [Abstract][Full Text] [Related]
34. SOX9 expression predicts relapse of stage II colon cancer patients.
Marcker Espersen ML; Linnemann D; Christensen IJ; Alamili M; Troelsen JT; Høgdall E
Hum Pathol; 2016 Jun; 52():38-46. PubMed ID: 26980019
[TBL] [Abstract][Full Text] [Related]
35. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
[TBL] [Abstract][Full Text] [Related]
36. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.
Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS
Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013
[TBL] [Abstract][Full Text] [Related]
37. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
38. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
[TBL] [Abstract][Full Text] [Related]
39. FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Lal A; Chan L; Devries S; Chin K; Scott GK; Benz CC; Chen YY; Waldman FM; Hwang ES
Breast Cancer Res Treat; 2013 Jun; 139(2):381-90. PubMed ID: 23712790
[TBL] [Abstract][Full Text] [Related]
40. Inclusion of BLIMP-1
Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
